Altered brain serotonin transporter and associated glucose metabolism in Alzheimer Disease

Journal of Nuclear Medicine

Volumn 50, Issue 8, 2009, Pages 1260-1266

  Ouchi, Yasuomi ^a,b   Yoshikawa, Etsuji ^c   Futatsubashi, Masami ^c   Yagi, Shunsuke ^a   Ueki, Takatoshi ^a   Nakamura, Kazuhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

^c CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

Alzheimer's disease; Depression; Glucose metabolism; Positron emission tomography; Serotonin transporter

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE C 11; BENZONITRILE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ALZHEIMER DISEASE; ANILINE COMPOUNDS; BRAIN; DEPRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SULFIDES; TISSUE DISTRIBUTION;

EID: 68249152023     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.063008     Document Type: Article

References (40)

1. Lanctôt KL, Herrmann N, Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2001; 13:5-21.
2. Mann DM, Yates PO. Serotonin nerve cells in Alzheimer's disease [letter]. J Neurol Neurosurg Psychiatry. 1983;46:96.
3. Palmer AM, Francis PT, Benton JS, et al. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem. 1987;48:8-15.
4. Assal F, Alarcón M, Solomon EC, Masterman D, Geschwind DH, Cummings JL. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol. 2004;61:1249-1253.
5. Curcio CA, Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol. 1984;43:359-368.
6. Zubenko GS, Moossy J, Martinez AJ, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol. 1991;48:619-624.
7. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry. 1990;157:894-901.
8. Petracca G, Tesón A, Chemerinski E, Leiguarda R, Starkstein SE. A doubleblind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1996;8:270-275.
9. Kepe V, Barrio JR, Huang SC, et al. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci USA. 2006;103:702-707.
10. Meltzer CC, Smith G, DeKosky ST, et al. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology. 1998;18:407-430.
11. 18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease. Neuroimage. 2008;40:1251-1256.
12. Lavoie B, Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol. 1990;299:1-16.
13. Lavoie B, Parent A. Serotoninergic innervation of the thalamus in the primate: an immunohistochemical study. J Comp Neurol. 1991;312:1-18.
14. Thomas AJ, Hendriksen M, Piggott M, et al. A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathol Appl Neurobiol. 2006;32:296-303.
15. Levy-Cooperman N, Burhan AM, Rafi-Tari S, et al. Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease. J Psychiatry Neurosci. 2008;33:218-226.
16. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol. 2002;53:545-574.
17. Mann UM, Mohr E, Chase TN. Rapidly progressive Alzheimer's disease [letter]. Lancet. 1989;2:799.
18. Ouchi Y, Nakayama T, Kanno T, Yoshikawa E, Shinke T, Torizuka T. In vivo presynaptic and postsynaptic striatal dopamine functions in idiopathic normal pressure hydrocephalus. J Cereb Blood Flow Metab. 2007;27:803-810.
19. Weintraub D, Xie S, Karlawish J, Siderowf A. Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15). Int J Geriatr Psychiatry. 2007;22:1025-1030.
20. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol. 1999;45:601-610.
21. Sekine Y, Ouchi Y, Takei N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry. 2006;63:90-100.
22. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-388.
23. Palacios JM,Waeber C, Hoyer D, Mengod G. Distribution of serotonin receptors. Ann N Y Acad Sci. 1990;600:36-52.
24. Mai JK, Assheuer J, Paxinos G. Atlas of the Human Brain. San Diego, CA: Academic Press; 1997.
25. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994;14:995-1010.
26. Procter AW, Lowe SL, Palmer AM, et al. Topographical distribution of neurochemical changes in Alzheimer's disease. J Neurol Sci. 1988;84:125-140.
27. Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Kaneko M. Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism. Neuroimage. 2004;22:155-163.
28. Yamamoto T, Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol. 1985;17:573-577.
29. Hendricksen M, Thomas AJ, Ferrier IN, Ince P, O'Brien JT. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Am J Psychiatry. 2004;161:1096-1102.
30. 11C](1)McN5652. Biol Psychiatry. 2002;51:715-722.
31. Li T, Holmes C, Sham PC, et al. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport. 1997;8:683-686.
32. Aucoin JS, Jiang P, Aznavour N, et al. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Neuroscience. 2005;132:73-86.
33. Holthoff VA, Beuthien-Baumann B, Kalbe E, et al. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry. 2005;57:412-421.
34. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675-682.
35. Kennedy SH, Evans KR, Krüger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry. 2001;158:899-905.
36. Grafman J, Schwab K, Warden D, Pridgen A, Brown HR, Salazar AM. Frontal lobe injuries, violence, and aggression: a report of the Vietnam Head Injury Study. Neurology. 1996;46:1231-1238.
37. Eustache F, Piolino P, Giffard B, et al. 'In the course of time': a PET study of the cerebral substrates of autobiographical amnesia in Alzheimer's disease. Brain. 2004;127:1549-1560.
38. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in agerelated neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004;27:589-594.
39. Nelson RL, Guo Z, Halagappa VM, et al. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol. 2007;205:166-176.
40. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990; 147:1049-1051.